PDA

View Full Version : Drugs and Drug Treatments


Pages : [1] 2 3 4 5

  1. Revlimid with Exjade
  2. withdrawal from cyclosporine?
  3. Results and side effects from Vidaza
  4. danazol and zenapax (daclizumab)
  5. Exjade and liver inflammation
  6. Vidaza disaster
  7. Giving Exjade a 2nd try
  8. Started Revlimid - good results
  9. Dacogen
  10. Neulasta
  11. ATG
  12. vidaza and itching
  13. Counts not recovering on Dacogen
  14. dacogen vs vidaza
  15. Re-starting Dacogen
  16. Did cyclosporine cause my lymphoma?
  17. Revlimid not holding up counts
  18. Tell me about Campath please
  19. After Revlimid
  20. Swelling of the face with Revlimid
  21. Dacogen and kidney problems
  22. Dacogen info seen on NOVA
  23. Romiplostim (AMG 531) for low platelets
  24. Low SerumEPO associated with good Aranesp/Procrit/Epogen response
  25. Eltrombopag can decrease leukemia cell proloferation
  26. Revlimid after Dacogen
  27. cGVHD
  28. Vidaza in Europe at last
  29. Aranesp
  30. Neupogen - Effects on Blood Tests?
  31. Aranest
  32. Aranesp
  33. solarimus
  34. Yahoo! One step closer to new platelet drug
  35. Which patients will respond to Revlimid ?
  36. How Dacogen is working
  37. Vidaza and MGCD0103
  38. Another delay with new platelet drug
  39. How long til Aranesp works?
  40. Info from FDA meeting about Nplate and MDS
  41. Decrease in Cyclosporine dose
  42. MDS - Vidaza tendinitis?
  43. ExJade-side effects?
  44. Anadrol for AA?
  45. TELINTRA in Phase II trials
  46. Gimotecan
  47. Eltrombopag for low platelets will perhaps be approved June 19
  48. We are moving ahead with Anadrol
  49. FDA Medwatch Warning on CellCept, have you seen this yet?
  50. Vidaza better than Dacogen?
  51. MDS treatment interesting video
  52. Epival
  53. Need info regarding Vidaza treatment
  54. idarubensin ara-c
  55. aranesp for mds
  56. New drug, Ceplene, could prevent ralapse of AML
  57. Revlimid not approved for MDS in EU due to risk för AML
  58. treatment for low wbcs?
  59. Side Effects of Revlimid
  60. Website with Adverse effects data
  61. Lytoxan chemotherapy treatment desperately sought
  62. New drug - MGCD0103 - can give heart symptoms
  63. Pulling Procrit
  64. Vidaza receives expanded FDA approval
  65. FDA approval for drug for low platelets
  66. About treatment with Revlimid (lenalidomide) and EPO
  67. New drug - sapacitabine - in phase II trial
  68. Fatigue with Aransep?
  69. New drug, ON 01910. Na, for MDS in Phase I trial
  70. Vitamin C may blunt effect of chemotherapy
  71. Clinical protocols
  72. Exjade
  73. Has anyone been on Dacogen plus valproic acid?
  74. Vidaza soon in EU
  75. Starting on Dacogen
  76. Leftover Cyclosporine
  77. 2nd round of dacogen
  78. The Doctor Came In Smileing Ear To Ear!
  79. Nellie's Journey on Vidaza
  80. Revlimid response, low platelets and transfusion independence
  81. Sapacitabine a new drug for MDS?
  82. Exjade and counts
  83. Problems with Vidaza
  84. Problems with Procrit
  85. Revlimid and low risk/high risk MDS
  86. kidney problems with cyclosporine
  87. For Helen about Telintra
  88. Imuran vs. generic?
  89. Report from the MDS Foundation Symposium
  90. Revlimid
  91. Cyclosporine + fluconazole
  92. Special changes that can lead to AML
  93. Thalidomide best for recently dx patients that only have anemia
  94. Vidaza vs Dacogen
  95. Cyclosporine dosage and troughs
  96. Recent article about treatment for MDS
  97. Megace/Oxandrin
  98. Article about TKL-199
  99. Using Dacogen for Long-Term Care
  100. Vidaza